|
| |
| | tetanus toxoid vaccine - [Medication] |
 | | Your doctor may recommend reducing pain or soreness from the injection by taking an aspirin-free pain reliever such as acetaminophen (Tylenol, Tempra, others) or ibuprofen (Motrin, Advil, others) when the shot is given and for the next 24-48 hours. | | | Your doctor or pharmacist may have additional information or suggest additional resources regarding tetanus toxoid vaccines. | | | Talk to your doctor before receiving tetanus toxoid vaccine if you are taking any of the following medications that may affect the immune system: |
|
http://www.peacehealth.org/kbase/multum/d01168n1.htm
|
|
| |
| | Tetanus Surveillance --- United States, 1998--2000 |
| | Health-care providers should evaluate their patients' tetanus vaccination status at each encounter and vaccinate as needed, which is critical among those patients in high-risk groups (e.g., older persons, diabetics, IDUs, persons with Hispanic ethnicity, pregnant women, persons with philosophical objections to vaccines, and persons who might not have received a primary series [e.g., immigrants]). | | | The immune response to tetanus toxoid can be less robust with increasing age, particularly among adults with chronic conditions ( 24,25). | | | All eight patients had nonwork-related acute injuries; six did not seek medical care before the onset of tetanus, and three were aged <20 years. |
|
http://www.cdc.gov/mmwr/preview/mmwrhtml/ss5203a1.htm
|
|
| |
| | Nat' Academies Press, Adverse Events Associated with Childhood Vaccines: Evidence Bearing on Casuality (1994) |
| | Antibody affinity and IgG subclass of responses to tetanus toxoid in patients with rheumatoid arthritis and systemic lupus erythematosus. | | | The absence of a delayed-type hypersensitivity response does not imply a lack of protective immunity, and conversely, a positive response does not appear to correlate with clinically important hypersensitivity reactions to the toxoid (Eisen et al., 1963; Facktor et al., 1973; Gold, 1941; Vellayappan and Lee, 1976). | | | Because the conclusions are not based on controlled studies, no estimate of incidence or relative risk is available. |
|
http://www.nap.edu/openbook/0309048958/html/67.html
|
|
| |
| | Influenza, Pneumococcal, and Tetanus Toxoid Vaccination of Adults --- United States, 1993--1997 |
| | For pneumococcal vaccine, a study documented that the sensitivity of self-reported data ranged from 87% to 97%, and specificity ranged from 53% to 76% ( 45). | | | NHIS data indicate that, in 1995, the Healthy People 2000 objective to increase annual influenza vaccination among persons aged > 65 years to at least 60% had been achieved among non-Hispanic whites; the overall national coverage level was within 2 percentage points of the objective. | | | Interventions (e.g., standing orders for vaccination [ 36 ], provider reminders and feedback, and patient recalls and reminders) have been effective in increasing adult vaccination levels ( 37,38). |
|
http://www.cdc.gov/mmwr/preview/mmwrhtml/ss4909a3.htm
|
|
| |
| | Connaught and the Defeat of Diphtheria |
| | Politics, a powerful medical profession, and the lack of a stable and inexpensive toxoid supply were the main obstacles there. | | | In the wake of these trials diphtheria incidence declined sharply in such cites as Toronto and Hamilton, dropping effectively to zero cases and zero deaths by the early 1930s (see figures). | | | Ramon's discovery of diphtheria toxoid was, like many great medical advances, accidental. |
|
http://www.healthheritageresearch.com/Diphtheria-conn9602.html
|
|
| |
| | Bioline International Official Site (site up-dated regularly) |
| | The serological assessment of a tetanus toxoid: field trial. | | | Since the effectiveness of tetanus toxoid immunization has been convincingly demonstrated in many field and hospital based studies (Newell et al 1971, Black et a! | | | This result indicates that asymptomatic Plasmodium falciparum parasiteamia did not pose any immediate threat to achieving the desired target for tetanus toxoid immunization. |
|
http://www.bioline.org.br/request?md03014
|
|
| |
| | Tetanus Toxoid USP detail at IndyaPharma |
| | Upon review, a report by the Institute of Medicine (IOM) concluded the evidence established a causal relationship between tetanus toxoid and anaphylaxis. | | | This should include a review of the patient's history with respect to possible sensitivity and any previous adverse reactions (see CONTRAINDICATIONS section) to the vaccine or similar vaccines and a current knowledge of the literature concerning the use of the vaccine under consideration. | | | A thorough attempt must be made to determine whether a patient has completed primary immunization. |
|
http://www.indyapharma.com/Tetanus-Toxoid-USP-detail.htm
|
|
| |
| | Tetanus Toxoid (Systemic) |
| | Before you receive tetanus toxoid, it is especially important that your health care professional know if you are using any prescription or nonprescription (over-the-counter [OTC]) medicine. | | | Make sure you tell your doctor if you have any other medical problems, especially: | | | • Severe illness with fever-Possible side effects from tetanus toxoid may be confused with the symptoms of the condition |
|
http://allnutritionals.com/drugs/t/tetanustoxoid-systemic.shtml
|
|
| |
| | Vaccine/Vaccination/Immunization Dangers -Tetanus Vaccine |
| | The Journal of Allergy and Clinical Immunology, 1973, carried an article entitled "Hypersensitivity to Tetanus Toxoid," and in a volume entitled "Proceedings of the II International Conference on Tetanus" (published by Hans Huber, Bern, Switzerland, 1967), an article appeared entitled "Clinical Reactions to Tetanus Toxoid." | | | TETANUS TOXOID VACCINATION An overview by Dr. Kris Gaublomme | | | Of patients with known illness outcome, the case-fatality ratio was 11%. |
|
http://www.nccn.net/~wwithin/tetanus.htm
|
|
| |
| | IV |
| | And it seemed reasonable enough to give them the choice, based upon the fact that you gave them the information upon which to base a choice." | | | The search for alternative sources was not successful. | | | Shortages may also have led to holding some anthrax vaccine in reserve to use along with antibiotics for unprotected servicemembers who may be exposed, and to acquiring botulinum anti-toxin for use under similar conditions. |
|
http://www.gulflink.osd.mil/va/va_s04.htm
|
|
| |
| | toxoid on Encyclopedia.com |
| | Inadvertent intradermal administration of tetanus toxoid-containing vaccines instead of tuberculosis skin tests.(Notice to Readers) | | | Neonatal immunization: response to Haemophilus influenzae type b-tetanus toxoid conjugate vaccine. | | | U.S. Food And Drug Administration Licenses INFANRIX(TM) (Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed) |
|
http://www.encyclopedia.com/html/t1/toxoid.asp
|
|
| |
| | Neonatal Tetanus |
| | Also, clean practices should be used during delivery and for the care of the infant's umbilical cord. | | | Even with specific therapy, and depending on the intensity of supportive care, lethality rates are still between 25% of 90% (1, 2). | | | Tetanus toxoid is used in three ways : · as a triple antigen with diphtheria toxoid and pertussis vaccine (adsorbed DTP) to provide basic immunity against tetanus to infants (three doses at 6,10 and 14 weeks), · as a double antigen DT to children up to 6 years. |
|
http://www.who.int/vaccines/en/neotetanus.shtml
|
|
| |
| | Adverse reactions to tetanus toxoid. (JAMA) |
| | Q A patient, previously immunized in the military, received a tetanus toxoid booster vaccination that resulted in a painful, | | | This patient most likely experienced an Arthus-type reaction, probably caused by multiple previous doses of the toxoid that | | | tetanus toxoid (ie, thimerosal) can lead to delayed-type hypersensitivity, while serum-sicknesslike illnesses appear to be rarely |
|
http://www.whale.to/vaccines/tetanus2.html
|
|
| |
| | Tetanus Toxoid Vaccine - Serum Institute of India Ltd. |
| | Only sterile needles and syringes should be used for each injection. | | | Sii Tetanus Toxoid (Adsorbed) should not be administered to infants or children with high fever, or other evidence of acute illness. | | | The specific contraindications adopted by individual national health authorities should reflect a balance between the risk from the vaccine and the risk from the disease. |
|
http://www.seruminstitute.com/content/products/product_tetanus_toxoid.htm
|
|
| |
| | Tetanus Toxoid |
| | Follow the full immunization schedule unless a medical problem arises that rules out receiving a vaccination. | | | Tetanus toxoid should not cause different or more severe side effects in older patients than in younger persons. | | | Tetanus toxoid stimulates the body's immune system to produce protective antibodies against tetanus. |
|
http://www.wholehealthmd.com/refshelf/drugs_view/1,1524,752,00.html
|
|
| |
| | Nature's Nutrition Store - News Archive: Toxoid Formula |
| | Thousands of testimonials have been received from people suffering from a wide range of health conditions including adhesions, arthritis, colitis, diverticulitis, wounds, scar tissue, moles, skin problems, rashes, inflammations, sore throats, surgery, warts, ulcers, burns and more! | | | Toxoid Formula acts as a catalyst to help the body heal and repair itself more effectively and efficiently. | | | Toxoid Formula is a remarkable product from Nutripathic Formulas that can help the body stimulate new cell growth. |
|
http://www.naturesnutrition.com/DATES/toxoid.htm
|
|
| |
| | Centers for Disease Control- Diptheria - Baby Bag® Online |
| | The major problems of diphtheria can be prevented in individual patients by adequate immunization with diphtheria toxoid. | | | Whether diphtheria toxoid is given by itself or in combination with tetanus toxoid or pertussis vaccine, the same level of immunity is produced in the body. | | | Diphtheria illness during pregnancy may be associated with an increased risk of miscarriages, premature delivery, or harmful effects to the unborn child. |
|
http://www.babybag.com/articles/cdc_dip.htm
|
|
| |
| | NOVA Online Bioterror Making Vaccines: Tetanus |
| | With a toxoid vaccine, the goal is to condition the immune system to combat not an invading virus or bacteria but rather a toxin produced by that invading virus or bacteria. | | | Even with the adjuvant, these vaccines do not produce a full immune response. | | | The vaccine for diphtheria -- also a toxoid vaccine -- is also often added to the tetanus/pertussis combo, making for the DPT vaccine. |
|
http://www.pbs.org/wgbh/nova/bioterror/vacc_tetanus.html
|
|
| |
| | Standing Orders for Administering Tetanus-Diphtheria Toxoid (Td) to Adults |
| | Screen all patients for contraindications and precautions to tetanus and diphtheria (Td) toxoid: | | | This policy and procedure shall remain in effect for all patients of the___________________ clinic until rescinded or until __________________ (date). | | | completion of a three-dose primary series of tetanus- and diphtheria-containing toxoids with the last dose having been given > 10 years previously |
|
http://www.immunize.org/catg.d/p3078.htm
|
|
| |
| | Communicable Disease Fact Sheet |
| | Tetanus immune globulin (TIG), antitoxin or antibiotics may be given if the patient has not been previously immunized with a series of at least three doses of toxoid. | | | An effective vaccine called tetanus toxoid has been available for many years. | | | Complications include spasm of the vocal cords and/or spasms of the respiratory muscles causing interference with breathing. |
|
http://www.health.state.ny.us/nysdoh/communicable_diseases/en/tetanus.htm
|
|
| |
| | Energy Citations Database (ECD) - Energy and Energy-Related Bibliographic Citations |
| | In the 200-rad experiment there was no evidence of inhibition at all. | | | The secondary response to tetanus toxoid was shown to be radiosensitive and to depend largely on the dose of radiation; a dose of 500 rad produced approximates 50% inhibition. | | | To investigate the problem, male PCT mice were immunized with two doses of tetanus toxoid at a 8-week interval, and their immune response to the second dose was tested by challenge with tetanus toxin 14 days later. |
|
http://www.osti.gov/energycitations/product.biblio.jsp?osti_id=4645335
|
|
| |
| | Murine Immune Response to Neisseria meningitidis Group C Capsular Polysaccharide: Analysis of Monoclonal Antibodies ... |
| | Molecular characterization of the humoral responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. | | | Murine Immune Response to Neisseria meningitidis Group C Capsular Polysaccharide: Analysis of Monoclonal Antibodies Generated in Response to a Thymus-Independent Antigen and a Thymus-Dependent Toxoid Conjugate Vaccine -- García-Ojeda et al. | | | Murine Immune Response to Neisseria meningitidis Group C Capsular Polysaccharide: Analysis of Monoclonal Antibodies Generated in Response to a Thymus-Independent Antigen and a Thymus-Dependent Toxoid Conjugate Vaccine |
|
http://iai.asm.org/cgi/content/full/68/1/239
|
|
| |
| | 028 Pa. Code § 23.83. Immunization requirements. |
| | Four or more properly-spaced doses of diphtheria toxoid, which may be administered as a single antigen vaccine, in combination with tetanus toxoid or in combination with tetanus toxoid and pertussis vaccine. | | | Four or more properly-spaced doses of tetanus toxoid, which may be administered as a single antigen vaccine, in combination with diphtheria toxoid or in combination with diphtheria toxoid and pertussis vaccine. | | | Three or more properly spaced doses of diphtheria toxoid, which may be administered as a single antigen vaccine, in combination with tetanus toxoid or in combination with tetanus toxoid and pertussis vaccine. |
|
http://www.pacode.com/secure/data/028/chapter23/s23.83.html
|
|
| |
| | Haemophilus b Conjugate Vaccine detail at IndyaPharma |
| | The toxoid is filter sterilized prior to the conjugation process. | | | However, the clinical significance of this difference is not known at present. | | | Therefore, in these situations it may be the judgment of the physician that it is of benefit to administer a single injection of whole-cell DTP or DTaP and Haemophilus b conjugate vaccines. |
|
http://www.indyapharma.com/Haemophilus-b-Conjugate-Vaccine-detail.htm
|
|
| |
| | AllRefer.com - toxoid (Pharmacology) - Encyclopedia |
| | Because toxoids can be given in large quantities with no risk of tissue damage, they have superseded the highly poisonous toxins as immunizing agents against such diseases as diphtheria and tetanus. | | | toxoid, protein toxin treated by heat or chemicals so that its poisonous property is destroyed but its capacity to stimulate the formation of toxin antibodies, or antitoxins, remains. | | | You are here : AllRefer.com > Reference > Encyclopedia > Pharmacology > toxoid |
|
http://reference.allrefer.com/encyclopedia/T/toxoid.html
|
|
| |
| | Tetanus Toxoid (002324) - Mosby's |
| | If the vial is used, rather than the Tubex Sterile Cartridge-Needle Unit, a separate syringe and needle which have been adequately cleaned and sterilized should be used for each patient to prevent transmission of hepatitis B virus and other infectious agents from one person to another. | | | Individuals who have received no prior injections of tetanus toxoid, or who have received only one injection of tetanus toxoid should be given an adequate dose of tetanus immune globulin (human) at time of injury. | | | Tetanus Toxoid Adsorbed, Wyeth, is refined by methods which eliminate at least 97% of the nontoxoid nitrogen. |
|
http://www.vaccinationnews.com/DailyNews/March2002/TetToxMosbys.htm
|
|
| |
| | BioMed Central Full text Safety and immunogenicity of three doses of an eleven-valent diphtheria toxoid and tetanus ... |
| | The study preceded a large-scale study, started in July 2000 in the Philippines, in which the effectiveness of the non-adjuvanted formulation of the vaccine is evaluated in prevention of radiologically confirmed pneumonia in children. | | | This report describes a safety and immunogenicity study of an aluminium adjuvanted eleven-valent mixed carrier diphtheria toxoid and tetanus protein-conjugated pneumococcal vaccine in Filipino infants. | | | The GMCs of antibodies against several serotypes such as 7F, 14 and 19F were considerably high at 6 weeks, but the detailed analysis of antibody responses to each vaccine dose did not support the hypothesis of interference in immune response due to pre-existing antibodies [ 9 ]. |
|
http://www.biomedcentral.com/1471-2334/3/17
|
|
| |
| | Tripedia Online, Description, Chemistry, Ingredients - Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine - ... |
| | The adsorbed toxoids are combined with acellular pertussis concentrate, and diluted to a final volume using sterile phosphate-buffered physiological saline. | | | This is represented in the final vaccine as approximately 23.4 µg of inactivated PT (also referred to as lymphocytosis promoting factor or LPF) and 23.4 µg of FHA. | | | Acellular Pertussis Vaccine Concentrates (For Further Manufacturing Use) are produced by The Research Foundation for Microbial Diseases of Osaka University (BIKEN), Osaka, Japan under United States (US) license, and are combined with diphtheria and tetanus toxoids manufactured by AvP. |
|
http://www.rxlist.com/cgi/generic2/tripedia.htm
|
|
| |
| | Major Infections |
| | If tetanus develops, treatment consists of airway maintenance and the use of muscle relaxants, such as diazepam (Valium), or a neuromuscular blocker. | | | Patients who have no previous immunization need tetanus immune globulin or tetanus antitoxin for temporary protection, followed by immunization with tetanus toxoid. | | | Those who have not been immunized in the past five years need a booster shot of tetanus toxoid. |
|
http://www.healthsquare.com/mc4infections.htm
|
|
| |
| | Diphtheria toxoid |
| | Vaccine presentation : The triple vaccine is usually used in preschool children for primary and reinforcing immunization, while bivalent vaccine is used for booster doses in preschool children in its paediatric form (DT). | | | Outbreaks : The public health burden of diphtheria has been low in most developing countries because most children have acquired immunity through subclinical or cutaneous infection. | | | The Td vaccine is used from seven years of age because of the possibility that individuals may have been either subclinically infected by toxigenic Corynebacterium diphtheriae or vaccinated during infancy, thus making them at increased sensitivity to the diphtheria component. |
|
http://www.who.int/vaccines/en/diptheria.shtml
|
|
| |
| | PRESS RELEASE Safety and Immunogenicity Results Available for New Tetanus Toxoid, Reduced Diphtheria Toxoid and ... |
| | WASHINGTON, DC -- (MARKET WIRE) -- 11/01/2004 -- GlaxoSmithKline (NYSE: GSK) today reported results from a pivotal clinical study of its booster vaccine candidate, Boostrix™ [Tetanus Toxoid, Reduced Diphtheria Toxoid and Acellular Pertussis Vaccine, Adsorbed (Tdap)]. | | | The Phase III clinical trial involved over 4,000 adolescents in the United States and showed Boostrix to be comparable to a U.S.-licensed Tetanus Diphtheria (Td) vaccine with regard to safety and immunogenicity. | | | In addition, the use of Boostrix induced anti-pertussis antibody levels which exceeded (by 1.8 to 6.9 times) those observed in infants following primary immunization with a DTaP vaccine (Infanrix®) [Diphtheria and Tetanus Toxoids and Acellular Pertussis Vaccine Adsorbed] in whom efficacy against pertussis disease was demonstrated in a previous study. |
|
http://www.marketwire.com/mw/release_html_b1?release_id=75162
|
|
| |
| | diphtheria toxoid |
| | formaldehyde inactivated toxin of Corynebacterium diphtheriae; generally used in mixtures with tetanus toxoid and pertussis vaccine; (DTP); or with tetanus toxoid alone (DT for pediatric use and Td, which contains 5 to 10 fold less diphtheria toxoid, for other use); diphtheria toxoid is used for the prevention of diphtheria. |
|
http://crisp.cit.nih.gov/Thesaurus/00002376.htm
|
|
| |
| | Activation of Human T Cells by Major Histocompatability Complex Class II Expressing Neutrophils: Proliferation in the ... |
| | These results delineate a new pathway for T-cell activation by SAg that may play an important role in the severity of SAg-induced inflammatory responses. | | | Tetanus toxoid (TT), a soluble protein Ag which requires processing before presentation, was not presented by GM-CSF-treated (HLA-DR This is despite the fact that T cells from these individuals exhibited a potent response to TT in the presence of professional APC. | | | From the Department of Physiology, Dartmouth-Hitchcock Medical Center, Lebanon, NH; and the Department of Microbiology, Immunology and Molecular Genetics, and Department of Pathology and Laboratory Medicine, Cellular Immunology Laboratory, Albany Medical College, Albany, NY. |
|
http://www.bloodjournal.org/cgi/content/full/89/11/4128
|
|
| |
| | Drug Shortage Bulletin: Tetanus Toxoid—Resolved |
| | William L. Atkinson, MD, MPH, National Immunization Program, Centers for Disease Control and Prevention (personal communication). | | | Aventis received approval from FDA May 15, 2002, for the licensing of Daptacel, a DTaP vaccine. | | | Diphtheria, tetanus, and pertussis: recommendations for vaccine use and other preventive measuresâ”recommendations of the Immunization Practices Advisory Committee (ACIP). |
|
http://www.ashp.org/shortage/tetanus-update.cfm
|
|
| |
| | MSN Encarta - Search Results - toxoid |
| | The Atomic Energy Commission reported in 1947 that during the first year of use of radioactive isotopes in medical, biological, industrial, and agricultural research, 1,092 shipments of more than 100 different isotopes were made to 170 institutions and researchers in 92 localities in the United... | | | Search Amazon.com for books about your topic, "toxoid" | | | Exclusively for MSN Encarta Premium Subscribers--quickly search thousands of articles from magazines such as Time, Newsweek, The Atlantic Monthly, and Smithsonian. |
|
http://encarta.msn.com/toxoid.html
|
|
|
